Preprint: T cell correction pipeline for Inborn Errors of Immunity
We’re excited to present our newest paper, currently in preprint!
Catch up on the latest news about what we’ve been up to and what’s happening at Haapaniemi Lab, including new job openings, research updates, new publications and team events.
We’re excited to present our newest paper, currently in preprint!
We’re excited to present our newest publication, published in the STAR Protocols journal in December 2023.
We are working on editing defective genes with CRISPR, a method we hope can cure all primary immunodeficiency diseases in the future. The technique we
Our group leader was interviewed in Apollon, the award-winning magazine published by the University of Oslo.
We are very proud to be part of Precision Immunotherapy Alliance “PRIMA”, a new Center of Excellence recently founded by The Research Council of Norway!
Aftenposten run a focused life science collection. Our laboratory was featured as representatives of NCMM in an article about new therapies for serious diseases in
Kata presented her work on CRISPR-Cas9 T cell pipeline optimisation at the American Society for Gene and Cell Therapy (ASGCT) conference in Washington D.C. The
We’ve now deposited the main plasmids from the following publication by Reint et al. to Addgene for distribution to the research community. Rapid Genome Editing
We are delighted to present our newest article, “Rapid genome editing by CRISPR-Cas9-POLD3 fusion”, published in eLife in December 2021. Abstract Precision CRISPR gene editing relies on
Zhuokun Li won the Best Poster Award at the annual CRISPR meeting at the Wellcome Trust Sanger Institute.